These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15320847)

  • 21. Learning from rejection: what transplantation teaches us about (other) vascular pathologies.
    Mitchell RN
    J Autoimmun; 2013 Sep; 45():80-9. PubMed ID: 23830871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of the FAST-1 transcription factor in coronary artery transplant vasculopathy and activated vascular smooth muscle cells.
    Kelemen SF; Eisen HJ; Autieri MV
    J Heart Lung Transplant; 2005 Mar; 24(3):246-50. PubMed ID: 15737749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of RNA interference targeting mammalian target of rapamycin on the proliferation of vascular smooth muscle cell and the intimal hyperplasia].
    Hu XH; Zhang Q; Yang J; Liu CW; Zhang ZS; Yang DH
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(1):58-62. PubMed ID: 17403315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adipokines enhance oleic acid-induced proliferation of vascular smooth muscle cells by inducing CD36 expression.
    Schlich R; Lamers D; Eckel J; Sell H
    Arch Physiol Biochem; 2015; 121(3):81-7. PubMed ID: 26135380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Smooth muscle cell-driven vascular diseases and molecular mechanisms of VSMC plasticity.
    Frismantiene A; Philippova M; Erne P; Resink TJ
    Cell Signal; 2018 Dec; 52():48-64. PubMed ID: 30172025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac allograft vasculopathy: advances in understanding its pathophysiology, prevention, and treatment.
    Pinney SP; Mancini D
    Curr Opin Cardiol; 2004 Mar; 19(2):170-6. PubMed ID: 15075747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New Targets for the Prevention of Chronic Rejection after Thoracic Organ Transplantation.
    Heim C; Gocht A; Weyand M; Ensminger S
    Thorac Cardiovasc Surg; 2018 Jan; 66(1):20-30. PubMed ID: 29258125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Soluble Jagged-1 inhibits restenosis of vein graft by attenuating Notch signaling.
    Zhou X; Xiao Y; Mao Z; Huang J; Geng Q; Wang W; Dong P
    Microvasc Res; 2015 Jul; 100():9-16. PubMed ID: 25660475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pitavastatin suppresses acute and chronic rejection in murine cardiac allografts.
    Suzuki J; Koga N; Kosuge H; Ogawa M; Haraguchi G; Maejima Y; Saiki H; Isobe M
    Transplantation; 2007 Apr; 83(8):1093-7. PubMed ID: 17452900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antisense extracellular signal-regulated kinase-2 gene therapy inhibits platelet-derived growth factor-induced proliferation, migration and transforming growth factor-beta(1) expression in vascular smooth muscle cells and attenuates transplant vasculopathy.
    Chen XL; Chen ZS; Ding Z; Dong C; Guo H; Gong NQ
    Transpl Int; 2008 Jan; 21(1):30-8. PubMed ID: 17927678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. S100B promotes injury-induced vascular remodeling through modulating smooth muscle phenotype.
    Cao T; Zhang L; Yao LL; Zheng F; Wang L; Yang JY; Guo LY; Li XY; Yan YW; Pan YM; Jiang M; Chen L; Tang JM; Chen SY; Wang JN
    Biochim Biophys Acta Mol Basis Dis; 2017 Nov; 1863(11):2772-2782. PubMed ID: 28693920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Common protective and diverse smooth muscle cell effects of AAV-mediated angiopoietin-1 and -2 expression in rat cardiac allograft vasculopathy.
    Nykänen AI; Pajusola K; Krebs R; Keränen MA; Raisky O; Koskinen PK; Alitalo K; Lemström KB
    Circ Res; 2006 Jun; 98(11):1373-80. PubMed ID: 16690881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment with telmisartan attenuates graft arteriosclerosis in murine cardiac allografts.
    Kosuge H; Ishihara T; Haraguchi G; Maejima Y; Okada H; Saiki H; Suzuki J; Isobe M
    J Heart Lung Transplant; 2010 May; 29(5):562-7. PubMed ID: 20044279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of membrane-type 1 matrix metalloproteinase in coronary vessels of allotransplanted primate hearts.
    Tsukioka K; Suzuki J; Kawauchi M; Wada Y; Zhang T; Nishio A; Koide N; Endoh M; Takayama K; Takamoto S; Isobe M; Amano J
    J Heart Lung Transplant; 2000 Dec; 19(12):1193-8. PubMed ID: 11124489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of PDGF-responsive genes in vascular smooth muscle. Implications for the early response to vessel injury.
    Marmur JD; Poon M; Rossikhina M; Taubman MB
    Circulation; 1992 Dec; 86(6 Suppl):III53-60. PubMed ID: 1424052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulating the regulators: transcription factors as targets for attenuating proliferative arteriopathies.
    Autieri MV
    Drug News Perspect; 2003 Apr; 16(3):149-58. PubMed ID: 12819813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of transplant vasculopathy in aortic allografts correlates with neointimal smooth muscle cell proliferative capacity and fibrocyte frequency.
    Onuta G; van Ark J; Rienstra H; Boer MW; Klatter FA; Bruggeman CA; Zeebregts CJ; Rozing J; Hillebrands JL
    Atherosclerosis; 2010 Apr; 209(2):393-402. PubMed ID: 19913790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics of cardiac allograft vasculopathy induced by immunomodulation in the miniature Swine.
    Amano J; Akashima T; Terasaki T; Wada Y; Ito-Amano M; Suzuki J; Isobe M
    Ann Thorac Cardiovasc Surg; 2015; 21(1):45-52. PubMed ID: 24747545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of immunosuppressive drugs on the development of cardiac allograft vasculopathy.
    Dandel M; Hetzer R
    Curr Vasc Pharmacol; 2010 Sep; 8(5):706-19. PubMed ID: 20649510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The lignan (+)-episesamin interferes with TNF-α-induced activation of VSMC via diminished activation of NF-ĸB, ERK1/2 and AKT and decreased activity of gelatinases.
    Freise C; Querfeld U
    Acta Physiol (Oxf); 2015 Mar; 213(3):642-52. PubMed ID: 25267105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.